Translate

The Know ALL website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know ALL cannot guarantee the accuracy of translated content. Know ALL and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

About UsUnderstanding ALLInterviewsGlobal NetworkStoriesResources

What do we know about acute lymphoblastic leukemia development and treatment?

Charles Mullighan

August 6, 2021

Know ALL was pleased to speak to Charles Mulligan, St Jude Children's Research Hospital, Memphis, US. We asked, What do we know about acute lymphoblastic leukemia development and treatment?

Mulligan explains what acute lymphoblastic leukemia is and how the affected cells change and lead to symptoms. He describes how treatments are administered to patients and why. Mulligan outlines groups of patients that are at risk of acute lymphoblastic leukemia development and the impact age has on this. Finally, he discusses how the treatment of ALL has changed over the years and highlights the success of chimeric antigen receptor (CAR) T-cell therapy.